D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
CALL
Marathon Petroleum
MPC
$90.3B
| $12.7M | 0.02% |
212,700
+78,400
| +58% | +$4.93M |
|
927
CenterPoint Energy
CNP
$29.1B
| $12.7M | 0.02% |
414,324
-502,064
| -55% | -$15.2M |
|
|
NAV
928
DELISTED
Navistar International
NAV
| $12.7M | 0.02% |
393,444
+69,439
| +21% | +$2.31M |
|
929
Alkermes
ALKS
$8.82B
| $12.7M | 0.02% |
347,758
+232,885
| +203% | +$7.69M |
|
930
Oceaneering
OII
$5.25B
| $12.7M | 0.02% |
803,824
+117,136
| +17% | +$1.81M |
|
931
Medpace
MEDP
$16.8B
| $12.6M | 0.02% |
214,172
-85,293
| -28% | -$5.09M |
|
932
Open Text
OTEX
$5.43B
| $12.6M | 0.02% |
327,259
+18,526
| +6% | +$677K |
|
|
TIF
933
PUT
DELISTED
Tiffany & Co.
TIF
| $12.6M | 0.02% |
119,100
+99,100
| +496% | +$9.1M |
|
|
FIT
934
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $12.5M | 0.02% |
+2,118,586
| New | +$12.9M |
|
935
DaVita
DVA
$15.1B
| $12.5M | 0.02% |
230,974
-115,117
| -33% | -$6.37M |
|
|
ECHO
936
EchoStar
ECHO
$25.5B
| $12.5M | 0.02% |
424,394
+105,858
| +33% | +$3.34M |
|
937
Shopify
SHOP
$148B
| $12.5M | 0.02% |
605,550
-1,277,800
| -68% | -$22.6M |
|
938
Rockwell Automation
ROK
$51.4B
| $12.5M | 0.02% |
71,122
-42,634
| -37% | -$7.25M |
|
|
ABMD
939
CALL
DELISTED
Abiomed Inc
ABMD
| $12.5M | 0.02% |
43,600
-18,200
| -29% | -$6.05M |
|
940
SEI Investments
SEIC
$11.9B
| $12.4M | 0.02% |
238,224
+60,184
| +34% | +$3.01M |
|
941
Standard BioTools
LAB
$326M
| $12.4M | 0.02% |
933,689
+712,728
| +323% | +$7.51M |
|
942
Hancock Whitney
HWC
$6.13B
| $12.4M | 0.02% |
306,950
-77,539
| -20% | -$3.18M |
|
|
WCG
943
DELISTED
Wellcare Health Plans, Inc.
WCG
| $12.4M | 0.02% |
45,882
-130,660
| -74% | -$33.8M |
|
944
CALL
Ford
F
$57.3B
| $12.4M | 0.02% |
1,409,300
+114,300
| +9% | +$982K |
|
|
SJR
945
DELISTED
Shaw Communications Inc.
SJR
| $12.4M | 0.02% |
593,039
-7,546
| -1% | -$153K |
|
946
JetBlue
JBLU
$1.96B
| $12.3M | 0.02% |
754,106
+265,314
| +54% | +$4.54M |
|
947
Churchill Downs
CHDN
$6.03B
| $12.3M | 0.02% |
272,142
+64,368
| +31% | +$2.87M |
|
948
Manhattan Associates
MANH
$8.97B
| $12.3M | 0.02% |
222,575
-1,496
| -0.7% | -$76.5K |
|
949
CALL
Deckers Outdoor
DECK
$13.3B
| $12.3M | 0.02% |
500,400
-137,400
| -22% | -$3.12M |
|
950
Hilton Grand Vacations
HGV
$3.84B
| $12.2M | 0.02% |
396,911
-651,355
| -62% | -$20M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.